The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Brazil’s exports to Kuwait rise 5.7%
- Uber launches fully driverless service in Dubai
- Syria seeks to revive oil industry
- Lola from Rio cosmetics reach 50 countries
- Olive oil exports boost Tunisia’s agriculture
- Algeria and Morocco at Women’s World Cup
- Jordan’s tourism revenue rises in July
- Brazil’s rare earths: Benefits and challenges
